MOSINI, GIULIA
MOSINI, GIULIA
Universita' degli Studi di MILANO
Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
2024 G. Cirnigliaro, V. Battini, M. Castiglioni, M. Renne, G. Mosini, S. Cheli, C. Carnovale, B. Dell'Osso
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
2023 V. Battini, G. Cirnigliaro, L. Giacovelli, M. Boscacci, S. MASSARA MANZO, G. Mosini, G. Guarnieri, M. Gringeri, B. Benatti, E.G.I. Clementi, D. Bernardo, C. Carnovale
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study
2023 A. Bombelli, G. Guarnieri, N. Lombardi, M.G. Sullo, E. Spina, G. Crescioli, C. Rafaniello, G. Cicala, V. Marangon, R. Folchino, S. Vecchio, G. Mosini, S. Radice, E. Clementi
Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting
2023 G. Cirnigliaro, V. Battini, R. Cafaro, G. Mosini, S. Vanzetto, T. Prodi, M. Macellaro, R. Leuzzi, D. Conti, C. Carnovale, B. Dell'Osso
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
2023 V. Battini, G. Cirnigliaro, R. Leuzzi, E. Rissotto, G. Mosini, B. Benatti, M. Pozzi, M. Nobile, S. Radice, C. Carnovale, B. Dell'Osso, E. Clementi
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
2023 V. Battini, R.P. Van Manen, M. Gringeri, G. Mosini, G. Guarnieri, A. Bombelli, M. Pozzi, M. Nobile, S. Radice, E. Clementi, C. Carnovale
On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review
2023 V. Battini, S. Rocca, G. Guarnieri, A. Bombelli, M. Gringeri, G. Mosini, M. Pozzi, M. Nobile, S. Radice, E. Clementi, A. Schindler, C. Carnovale, N. Pizzorni
Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review
2022 V. Battini, A. Mari, M. Gringeri, F. Casini, F. Bergamaschi, G. Mosini, G. Guarnieri, M. Pozzi, M. Nobile, G.V. Zuccotti, E. Clementi, S. Radice, V. Fabiano, C. Carnovale
Reply to: correspondence on "Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis"
2022 M. Gringeri, V. Battini, G. Cammarata, G. Mosini, G. Guarnieri, C. Leoni, M. Pozzi, S. Radice, E. Clementi, C. Carnovale
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis
2022 M. Gringeri, V. Battini, G. Cammarata, G. Mosini, G. Guarnieri, C. Leoni, M. Pozzi, S. Radice, E. Clementi, C. Carnovale
Pneumatosis Intestinalis Induced by Anticancer Treatment: A Systematic Review
2022 G. Gazzaniga, F. Villa, F. Tosi, E.G. Pizzutilo, S. Colla, S. D'Onghia, G. Di Sanza, G. Fornasier, M. Gringeri, M.V. Lucatelli, G. Mosini, A. Pani, S. Siena, F. Scaglione, A. Sartore-Bianchi
Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility
2021 M. Gringeri, G. Mosini, V. Battini, G. Cammarata, G. Guarnieri, C. Carnovale, E. Clementi, S. Radice
The impact of anti-TNFα agents on weight-related changes : new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
2021 F. Mazhar, V. Battini, M. Gringeri, M. Pozzi, G. Mosini, A.M.N. Marran, S. Akram, R.P. van Manen, S. Radice, E. Clementi, C. Carnovale
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: A network meta-analysis and regression
2021 C. Carnovale, E. Lucenteforte, V. Battini, F. Mazhar, M. Fornili, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, M. Nobile, C. Vantaggiato, S. Pisano, C. Bravaccio, S. Radice, E. Clementi, M. Pozzi
β-blockers associated hypoglycaemia: new insights from a real-world pharmacovigilance study [Beta-blocker-associated hypoglycaemia: New insights from a real-world pharmacovigilance study]
2021 C. Carnovale, M. Gringeri, V. Battini, G. Mosini, E. Invernizzi, F. Mazhar, F. Bergamaschi, M. Fumagalli, G.V. Zuccotti, E.G.I. Clementi, S. Radice, V. Fabiano
Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review
2021 F. Mazhar, V. Battini, M. Pozzi, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, S. Radice, E. Clementi, C. Carnovale
The use of biological agents in pregnant women affected by autoimmune disorders : Why we need more research of this neglected area
2021 C. Carnovale, F. Parisi, V. Battini, A. Zavatta, S. Cheli, D. Cattaneo, M. Gringeri, G. Mosini, G. Guarnieri, G. Cammarata, I. Cetin
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
2020 F. Mazhar, V. Battini, M. Pozzi, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, S. Radice, E. Clementi, C. Carnovale
Are dizziness-related symptoms signals for suboptimal treatment of hypothyroidism? New insights from the FDA adverse event reporting system (FAERS) database
2020 C. Carnovale, V. Battini, F. Mazhar, G. Mosini, M. Gringeri, A. Vicenzi, E. Clementi, S. Radice
Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn’s disease patients with perianal lesions: a systematic review
2020 C. Carnovale, A. Maffioli, G. Zaffaroni, F. Mazhar, V. Battini, G. Mosini, M. Pozzi, S. Radice, E. Clementi, P. Danelli